BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Structural Analysis of Gluco-Oligosaccharides Produced by <i>Leuconostoc lactis</i> and Their Prebiotic Effect. ✅
Molecules (Basel, Switzerland) (Molecules ) Vol: 24 Issue 21 Pages: Pub: 2019 Nov 5 Epub: 2019 Nov 5 Authors Lee S , Park J , Jang JK , Lee BH , Park YS , |
|
|
Structural Analysis of Gluco-Oligosaccharides Produced by <i>Leuconostoc lactis</i> and Their Prebiotic Effect. ✅
Molecules (Basel, Switzerland) (Molecules ) Vol: 24 Issue 21 Pages: Pub: 2019 Nov 5 Epub: 2019 Nov 5 Authors Lee S , Park J , Jang JK , Lee BH , Park YS , |
|
|
In vitro fermentation of commercial a-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. ✅
Go to Publication ✅
The British journal of nutrition (Br J Nutr ) Vol: 109 Issue 11 Pages: 1980-9 Pub: 2013 Jun Epub: 2012 Nov 2 Authors Sarbini SR , Kolida S , Gibson GR , Rastall RA , |
|
|
In vitro fermentation of commercial a-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. ✅
Go to Publication ✅
The British journal of nutrition (Br J Nutr ) Vol: 109 Issue 11 Pages: 1980-9 Pub: 2013 Jun Epub: 2012 Nov 2 Authors Sarbini SR , Kolida S , Gibson GR , Rastall RA , |
|
|
In vitro fermentation of commercial a-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. ✅
Go to Publication ✅
The British journal of nutrition (Br J Nutr ) Vol: 109 Issue 11 Pages: 1980-9 Pub: 2013 Jun Epub: 2012 Nov 2 Authors Sarbini SR , Kolida S , Gibson GR , Rastall RA , |
|
|
In vitro fermentation of commercial a-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. ✅
Go to Publication ✅
The British journal of nutrition (Br J Nutr ) Vol: 109 Issue 11 Pages: 1980-9 Pub: 2013 Jun Epub: 2012 Nov 2 Authors Sarbini SR , Kolida S , Gibson GR , Rastall RA , |
|
|
The role of short-chain fatty acids in microbiota-gut-brain communication. ✅
Go to Publication ✅
Nature reviews. Gastroenterology & hepatology (Nat Rev Gastroenterol Hepatol ) Vol: 16 Issue 8 Pages: 461-478 Pub: 2019 Aug Epub: Authors Dalile B , Van Oudenhove L , Vervliet B , Verbeke K , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
